Despite the recent downward trend in DOJ healthcare industry settlements, the first quarter of 2024 saw many noteworthy False Claims Act (FCA) and civil healthcare fraud settlements related to alleged kickbacks, medically unnecessary services and equipment, pharmaceutical issues and Controlled Substances Act violations.

Continue Reading False Claims Act Settlements to Know from Q1 2024

The United States notified the U.S. District Court for the Northern District of Georgia that it plans to intervene in a False Claims Act case filed against Georgia Tech Research Corporation (Georgia Tech) by its Associate Director of Cybersecurity and former Principal Information Security Engineer (the relators). 

Continue Reading The United States Intervenes in its First False Claims Act Cybersecurity Case

Bass, Berry & Sims released its 12th Annual Healthcare Fraud & Abuse Review on February 26, 2024. As a companion to the Review, we hosted a complimentary webinar which provided an overview and discussion of key focus areas covered in the Review. We are pleased to offer an encore presentation of this webinar on April 25, 2024.

Continue Reading Register Now | Healthcare Fraud & Abuse Annual Review Webinar Replay

In 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) offered the industry new and updated guidance tools and a late flurry of advisory opinions. Join us for a webinar in which we will provide a high-level overview of 2023’s most significant and helpful guidance documents.

Continue Reading Register Now | HHS-OIG Year in Review Webinar Replay

In a recent McKnight’s Long-Term Care News article, we discussed heighted scrutiny within the long-term care industry related to drug diversion and compliance with the Controlled Substances Act (CSA). Healthcare organizations, and not just diverting employees, are more often being held accountable for diversion of controlled substances.

Continue Reading Drug Diversion within Long-Term Care Industry

On February 8, the U.S. District Court for the District of Minnesota ruled that a $487 million False Claims Act (FCA) damages award entered last year against Precision Lens and its co-founder violated the Eighth Amendment’s prohibition on excessive fines and ordered the judgment reduced by more than half. 

Continue Reading District Court Finds that $487 Million False Claims Act Judgment Violates Eighth Amendment

In 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) offered the industry new and updated guidance tools and a late flurry of advisory opinions. Join us on February 27 from 12:00 p.m. – 1:00 p.m. CT for a webinar in which we will provide a high-level overview of 2023’s most significant and helpful guidance documents.  

Continue Reading Register Now | HHS-OIG Year in Review Webinar